Ryan Specialty (NYSE:RYAN) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Ryan Specialty (NYSE:RYAN) posted its earnings results on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02), Zacks reports. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%.

Ryan Specialty Trading Down 1.0 %

RYAN stock traded down $0.67 on Thursday, hitting $68.70. 697,095 shares of the company were exchanged, compared to its average volume of 947,339. The stock has a market capitalization of $17.99 billion, a price-to-earnings ratio of 89.23, a price-to-earnings-growth ratio of 1.21 and a beta of 0.72. The business’s fifty day moving average is $65.58 and its two-hundred day moving average is $67.25. Ryan Specialty has a twelve month low of $45.55 and a twelve month high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 10,485 shares of the business’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the completion of the sale, the director now owns 11,109 shares in the company, valued at approximately $723,418.08. The trade was a 48.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 316,451 shares of company stock valued at $20,907,793 in the last ninety days. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

RYAN has been the topic of several recent research reports. Wells Fargo & Company reduced their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday, January 10th. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $74.40.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.